Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis
Multiple sclerosis (MS) is a debilitating neurodegenerative disease characterized by demyelination and neuronal loss. Traditional therapies often fail to halt disease progression or reverse neurological deficits. Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative a...
Saved in:
Main Authors: | David Qixiang Chen, José Adalberto Inzunza Domínguez, Juan Manuel Valle Uzeta, Abhiram P. Pushparaj, Jonathan E. Dickinson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1535782/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effect of Sensorimotor Synchronization on Gait Spatiotemporal Parameters in Women with Multiple Sclerosis
by: Mozhgan Memarmoghadam, et al.
Published: (2024-11-01) -
Alexithymia in multiple sclerosis: past, present and future
by: Samar S. Ayache, et al.
Published: (2025-02-01) -
Investigating the Safety of Fampridine in Patients with Different Stages of Multiple Sclerosis
by: Saeed Vaheb, et al.
Published: (2025-01-01) -
The phytohormone abscisic acid enhances remyelination in mouse models of multiple sclerosis
by: Femke Van Gaever, et al.
Published: (2024-12-01) -
Corrigendum: The phytohormone abscisic acid enhances remyelination in mouse models of multiple sclerosis
by: Femke Van Gaever, et al.
Published: (2025-02-01)